Simulations Plus
Price
Price
CHART BY
Historical dividends and forecast
Simulations Plus has so far distributed $0.18 in 2024. The next dividend will be paid on 05.02.2025
CHART BY
Frequently asked questions
What is Simulations Plus's market capitalization?
What is Simulations Plus's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Simulations Plus?
What are the analyst ratings and target price for Simulations Plus's stock?
What is Simulations Plus's revenue over the trailing twelve months?
What is the EBITDA for Simulations Plus?
What is the free cash flow of Simulations Plus?
How many employees does Simulations Plus have, and what sector and industry does it belong to?
What is the free float of Simulations Plus's shares?
Financials
- Market Cap
- $573.52M
- EPS (TTM)
- $0.49
- Free Float
- 16.45M
- P/E ratio (TTM)
- 58.29
- Revenue (TTM)
- $70.01M
- EBITDA (TTM)
- $11.80M
- Free Cashflow (TTM)
- $12.75M
Pricing
- 52W span
- $27.12$51.22
Analyst Ratings
The price target is $50.00 and the stock is covered by 7 analysts.
Buy
6
Hold
1
Sell
0
Information
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.
- Employees
- 247
- Industries
- Packaged Software
- Sector
- Health Care
Identifier
- ISIN
- US8292141053
- Primary Ticker
- SLP